Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making
https://www.fool.com/investing/2024/05/04/move-over-mounjaro-eli-lilly-has-another-blockbust/?source=iedfolrf0000001
May 04, 2024 - Eli Lilly has made inroads in the red-hot weight-loss market thanks to its diabetes blockbuster, Mounjaro.
0
Eli Lilly (LLY) Q1 2024 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2024/04/30/eli-lilly-lly-q1-2024-earnings-call-transcript/?source=iedfolrf0000001
Apr 30, 2024 - LLY earnings call for the period ending March 31, 2024.
0
Eli Lilly Just Announced More Good News: Time to Buy?
https://www.fool.com/investing/2024/04/28/eli-lilly-just-announced-more-good-news-time-to-bu/?source=iedfolrf0000001
Apr 28, 2024 - There's no stopping this high-flying biotech.
0
Eli Lilly (LLY) Advances But Underperforms Market: Key Facts
https://www.zacks.com/stock/news/2259608/eli-lilly-lly-advances-but-underperforms-market-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2259608
Apr 22, 2024 - Eli Lilly (LLY) concluded the recent trading session at $731.33, signifying a +0.69% move from its prior day's close.
0
Missed Out on Eli Lilly and Novo Nordisk? This Small Biotech Has a Promising GLP-1 Drug With Significant Potential
https://www.fool.com/investing/2024/04/20/missed-out-eli-lilly-and-novo-nordisk-this-small/?source=iedfolrf0000001
Apr 20, 2024 - Altimmune has a modest market cap but an incredibly promising GLP-1 drug.
0
Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank
https://www.fool.com/investing/2024/04/17/why-eli-lilly-stock-beat-the-market-today-while-re/?source=iedfolrf0000001
Apr 17, 2024 - The company published some very good news from the lab, although it wasn't so encouraging for smaller rivals.
0
Top Research Reports for Eli Lilly, Linde & Caterpillar
https://www.zacks.com/commentary/2256781/top-research-reports-for-eli-lilly-linde-caterpillar?cid=CS-ZC-FT-research_daily-2256781
Apr 17, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Linde plc (LIN) and Caterpillar Inc. (CAT).
0
Eli Lilly (LLY) Stock Dips While Market Gains: Key Facts
https://www.zacks.com/stock/news/2256381/eli-lilly-lly-stock-dips-while-market-gains-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2256381
Apr 16, 2024 - In the closing of the recent trading day, Eli Lilly (LLY) stood at $749.26, denoting a -0.2% change from the preceding trading day.
0
Eli Lilly subsidiary, Precision Biosciences end gene therapy collaboration
https://seekingalpha.com/news/4090270-eli-lilly-subsidiary-precision-biosciences-end-gene-therapy-collaboration?source=feed_sector_healthcare
Apr 16, 2024 - Precision BioSciences (DTIL) said Eli Lilly (LLY) subsidiary Prevail Therapeutics has decided to conclude their gene therapy collaboration. Read more here.
0
Eli Lilly launches construction of $2.5B plant to meet obesity drug demand
https://seekingalpha.com/news/4088326-eli-lilly-eyes-25b-plant-make-obesity-drugs?source=feed_sector_healthcare
Apr 09, 2024 - Eli Lilly (LLY) begins construction of a $2.5B manufacturing plant in Germany to meet demand for its weight loss therapy tirzepatide. Read more here.
0
Page 1>